TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
RGEN

Repligen Corporation

Healthcare · Medical Instruments & Supplies

180.70$ +2.2% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RGEN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
70.6% 63.7% 201.6% 197.7% 45.8% 47.4% 39.5% 39.4% 39.3% 37.7% 38.6%
50.2% 49.1% 144.3% 139.0% 37.7% 37.7% 25.6% 20.7% 26.6% 26.8% 19.2%
50.2% 49.1% 144.3% 139.0% 37.7% 37.7% 25.6% 24.6% 26.6% 26.8% 26.0%
7.8% 5.6% 23.0% 25.6% 3.1% 3.8% 5.0% 4.6% 4.4% 4.7% 5.4%
12.3% 8.5% 32.4% 30.3% 3.9% 5.0% 7.8% 9.4% 7.2% 5.1% 5.8%
9.4% 5.2% 18.6% 23.1% 3.5% 3.5% 5.3% 7.5%
9.8% 20.6% 271.9% 234.3% 33.5% 32.5% 36.5% 33.8% 34.9% 36.4% 37.8%
8.7% 10.3% 120.2% 97.1% 15.2% 15.1% 14.3% 14.2% 14.2% 14.1% 13.1%
16.1% 41.6% 126.2% 114.1% 24.3% 19.6% 25.8% 24.5% 30.2% 30.3% 28.6%
12.8% 7.3% 20.9% 93.1% 3.5% 16.8% 15.9% 16.0% 5.6% 4.5% 4.6%
33.0% 82.4% 74.2% 0.3% 13.1% 11.2% 11.5% 2.7% 0.5% 0.7%
4.6% 1.8% 6.0% 7.5% 0.8% 0.9% 1.5% 1.1% 0.7% 1.1% 1.0%
0.0% 33.0% 82.4% 16.6% 18.1% 18.6% 18.4%
83.9% 58.4% -26.2% 441.4% 75.7% 80.4% 74.2% 75.5% 69.8% 69.7% 71.4%
-48.9% -20.7% -26.2% -11.2% 0.4% 3.5% 8.2% 15.7% 15.5% 14.4% 15.5%
23.0% 11.8% 32.5% 32.6% 3.5% 2.8% 2.4% 2.3% 2.0% 2.0% 1.9%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?